The results of the public data of BC patients demonstrated the persistent amplification of CREBBP gene in luminal A, luminal B and triple-negative subtypes, whereas no CREBBP amplification was observed in HER2 positive subtypes (Fig. 7a). This evidence concerns the gene CREBBP and breast cancer.